Overview

Pediatric Switch Study for Children and Adolescent Patients With Epilepsy

Status:
Completed
Trial end date:
2003-12-01
Target enrollment:
Participant gender:
Summary
To assess the tolerability of switching from Depakote Sprinkle Capsules or Depakote tablets to Depakote ER tablets in the pediatric population.
Phase:
Phase 2
Details
Lead Sponsor:
Abbott
Treatments:
Valproic Acid